bf/NASDAQ:EKSO_icon.jpeg

NASDAQ:EKSO

Ekso Bionics Holdings, Inc.

  • Stock

USD

Last Close

1.33

26/07 20:00

Market Cap

19.73M

Beta: 1.81

Volume Today

25.61K

Avg: 23.20K

PE Ratio

−2.21

PFCF: −2.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
311K
-
839K
169.77%
1.31M
55.66%
2.29M
75.38%
3.20M
39.62%
2.93M
8.38%
2.23M
23.77%
2.11M
5.53%
3.71M
76.04%
5.12M
37.80%
average payables
391.50K
-
1.74M
344.06%
2.29M
31.52%
2.15M
5.99%
2.79M
29.70%
2.53M
9.27%
1.70M
32.71%
2.30M
35.37%
3.13M
35.81%
2.50M
20.13%
average receivables
774.50K
-
1.81M
133.57%
1.92M
6.38%
2.27M
17.95%
3.21M
41.41%
4.43M
38.13%
4.30M
3.06%
4.03M
6.35%
4.64M
15.35%
5.13M
10.58%
book value per share
23.61
-
6.98
70.43%
5.40
22.58%
9.01
66.72%
0.67
92.58%
1.42
112.15%
0.62
56.35%
3.05
393.19%
1.96
35.70%
0.91
53.69%
capex per share
-1.54
-
-1.18
23.19%
-0.91
23.30%
-0.19
78.82%
-0.03
83.29%
-0.01
61.00%
-0.00
-
-0.01
209.31%
capex to depreciation
-2.00
-
-1.60
19.88%
-0.59
63.05%
-0.26
55.44%
-0.09
67.16%
-0.09
0.56%
-0.11
-
-0.22
107.96%
capex to operating cash flow
0.10
-
0.08
17.58%
0.04
46.31%
0.01
66.69%
0.01
59.53%
0.00
35.63%
0.01
-
0.01
149.74%
capex to revenue
-0.28
-
-0.17
38.29%
-0.08
55.26%
-0.06
19.53%
-0.01
81.36%
-0.00
62.71%
-0.01
-
-0.02
186.39%
cash per share
26.08
-
15.50
40.58%
13.94
10.04%
11.72
15.96%
1.88
83.99%
2.27
20.93%
1.80
20.83%
3.31
84.58%
1.58
52.22%
days of inventory on hand
60.25
-
51.52
14.50%
50.38
2.21%
208.96
314.79%
175.20
16.16%
127.01
27.51%
189.39
49.12%
181.97
3.92%
282.66
55.33%
200.35
29.12%
days payables outstanding
75.85
-
131.42
73.27%
60.83
53.71%
167.17
174.79%
164.02
1.88%
97.11
40.80%
143.72
48.01%
252.18
75.47%
171.71
31.91%
73.28
57.32%
days sales outstanding
106.14
-
87.19
17.85%
45.69
47.60%
137.01
199.88%
117.89
13.95%
136.59
15.86%
139.27
1.96%
151.31
8.65%
130.74
13.59%
112.72
13.78%
debt to assets
0.00
-
0.00
29.52%
0.28
11,175.89%
0.18
34.20%
0.28
53.04%
0.18
37.38%
0.19
5.96%
0.05
75.86%
0.18
305.99%
0.25
35.09%
debt to equity
0.01
-
0.01
75.50%
1.05
11,435.97%
0.33
68.75%
1.83
457.72%
0.57
68.80%
0.87
52.66%
0.06
93.14%
0.29
394.11%
0.57
92.76%
dividend yield
0.14
-
earnings yield
-0.24
-
-0.14
40.79%
-0.33
124.41%
-0.38
18.02%
-0.36
7.41%
-0.42
16.89%
-0.39
7.10%
-0.26
32.40%
-0.95
262.81%
-0.44
53.70%
enterprise value
112.85M
-
115.66M
2.49%
62.14M
46.27%
55.04M
11.43%
73.25M
33.09%
21.14M
71.14%
34.91M
65.13%
-5.87M
116.82%
2.40M
140.95%
41.84M
1,639.68%
enterprise value over ebitda
-6.70
-
-5.36
20.04%
-1.93
64.04%
-1.88
2.32%
-2.66
41.65%
-1.18
55.59%
-3.02
154.84%
0.40
113.24%
-0.15
138.65%
-2.77
1,694.25%
ev to operating cash flow
-7.52
-
-6.33
15.81%
-2.49
60.73%
-1.76
29.10%
-3.30
87.50%
-1.34
59.44%
-3.99
197.48%
0.53
113.20%
-0.16
131.10%
-3.47
2,019.83%
ev to sales
21.19
-
13.35
36.97%
4.37
67.28%
7.49
71.30%
6.46
13.64%
1.52
76.50%
3.93
158.74%
-0.52
113.29%
0.19
135.67%
2.29
1,128.88%
free cash flow per share
-17.08
-
-15.66
8.29%
-21.59
37.87%
-13.35
38.19%
-5.46
59.07%
-3.30
39.54%
-1.22
62.99%
-0.92
24.74%
-1.15
24.82%
-0.87
24.29%
free cash flow yield
-0.12
-
-0.15
22.29%
-0.36
147.33%
-0.42
15.49%
-0.29
29.70%
-0.56
91.58%
-0.20
64.56%
-0.35
74.10%
-0.96
177.97%
-0.35
63.96%
graham net net
16.55
-
-1.39
108.42%
0.88
163.24%
6.23
607.31%
-0.70
111.17%
0.19
127.10%
0.03
83.00%
2.71
8,358.81%
0.86
68.36%
-0.69
180.26%
graham number
136.27
-
49.38
63.76%
48.60
1.59%
49.87
2.62%
9.97
80.01%
8.82
11.54%
5.74
34.92%
6.89
20.05%
7.05
2.35%
4.73
32.88%
income quality
0.44
-
0.93
109.85%
1.07
14.21%
1.07
0.67%
0.82
23.42%
1.30
58.31%
0.55
57.44%
1.14
106.52%
0.97
14.75%
0.79
18.57%
intangibles to total assets
0
-
0.06
Infinity%
0.05
9.66%
0.02
64.02%
0.01
40.20%
0.01
19.44%
0
100%
0
0.14
Infinity%
0.18
33.31%
interest coverage
-38.61
-
-1.66K
4,195.96%
-162.27
90.22%
-48.78
69.94%
-45.05
7.65%
-43.33
3.82%
-92.50
113.48%
-122.37
32.29%
-99.72
18.51%
50.04
150.18%
interest debt per share
0.57
-
0.07
87.13%
5.80
7,773.63%
3.22
44.47%
1.37
57.58%
0.89
35.07%
0.56
37.19%
0.19
65.66%
0.59
208.63%
0.50
16.23%
inventory turnover
6.06
-
7.09
16.96%
7.25
2.26%
1.75
75.89%
2.08
19.27%
2.87
37.94%
1.93
32.94%
2.01
4.08%
1.29
35.62%
1.82
41.08%
invested capital
0.01
-
0.01
75.50%
1.05
11,435.97%
0.33
68.75%
1.83
457.72%
0.57
68.80%
0.87
52.66%
0.06
93.14%
0.29
394.11%
0.57
92.76%
market cap
137.93M
-
135.13M
2.03%
72.14M
46.61%
75.85M
5.14%
75.92M
0.10%
28.14M
62.94%
43.92M
56.06%
32.31M
26.42%
15.42M
52.26%
34.67M
124.75%
net current asset value
18.63M
-
1.81M
90.28%
2.79M
54.06%
18.34M
557.35%
40K
99.78%
3.69M
9,122.50%
2.26M
38.82%
35.85M
1,488.30%
15.58M
56.55%
3.90M
74.99%
net debt to ebitda
1.49
-
0.90
39.40%
0.31
65.62%
0.71
129.42%
0.10
86.32%
0.39
302.77%
0.78
98.56%
2.60
233.64%
0.84
67.81%
-0.47
156.78%
net income per share
-34.96
-
-15.53
55.59%
-19.42
25.09%
-12.27
36.84%
-6.61
46.10%
-2.44
63.11%
-2.37
2.98%
-0.69
70.78%
-1.13
62.92%
-1.10
2.72%
operating cash flow per share
-15.54
-
-14.48
6.81%
-20.69
42.87%
-13.15
36.41%
-5.43
58.72%
-3.29
39.41%
-1.22
62.85%
-0.91
25.13%
-1.13
23.85%
-0.87
23.29%
payables turnover
4.81
-
2.78
42.29%
6
116.04%
2.18
63.61%
2.23
1.92%
3.76
68.91%
2.54
32.43%
1.45
43.01%
2.13
46.86%
4.98
134.33%
receivables turnover
3.44
-
4.19
21.72%
7.99
90.85%
2.66
66.65%
3.10
16.22%
2.67
13.69%
2.62
1.92%
2.41
7.96%
2.79
15.73%
3.24
15.99%
research and ddevelopement to revenue
0.73
-
0.75
3.04%
0.62
16.55%
1.29
106.56%
0.52
59.99%
0.33
36.00%
0.28
15.66%
0.24
12.27%
0.28
14.93%
0.27
2.11%
return on tangible assets
-1.01
-
-0.64
36.17%
-1.01
57.05%
-0.78
22.81%
-1.55
97.98%
-0.54
65.17%
-0.82
52.93%
-0.17
79.16%
-0.41
141.54%
-0.64
55.49%
revenue per share
5.52
-
6.86
24.46%
11.77
71.44%
3.10
73.68%
2.78
10.37%
2.90
4.57%
1.24
57.29%
0.92
25.61%
1.00
8.00%
1.32
32.33%
roe
-1.48
-
-2.22
50.17%
-3.59
61.58%
-1.36
62.12%
-9.89
626.78%
-1.72
82.61%
-3.82
122.24%
-0.23
94.07%
-0.57
153.37%
-1.21
110.03%
roic
-0.72
-
-2.29
215.40%
-1.51
33.74%
-1.15
24.20%
-3.66
218.37%
-1.36
62.82%
-1.52
11.74%
-0.30
80.18%
-0.44
45.59%
-0.75
71.24%
sales general and administrative to revenue
1.39
-
0.81
41.80%
0.76
5.60%
1.46
90.94%
1.03
29.15%
0.53
48.44%
0.87
62.88%
0.94
7.92%
0.85
9.07%
0.59
31.25%
shareholders equity per share
23.61
-
6.98
70.43%
5.40
22.58%
9.01
66.72%
0.67
92.58%
1.42
112.15%
0.62
56.35%
3.05
393.19%
1.96
35.70%
0.91
53.69%
stock based compensation to revenue
0.21
-
0.20
6.85%
0.22
9.81%
0.40
81.13%
0.27
31.63%
0.17
36.63%
0.29
68.58%
0.22
23.44%
0.21
4.82%
0.10
51.96%
tangible asset value
22.80M
-
7.04M
69.14%
5.32M
24.43%
20.71M
289.60%
2.54M
87.74%
6.61M
160.26%
4.43M
32.90%
37.22M
739.40%
19.79M
46.82%
7.28M
63.21%
tangible book value per share
23.61
-
5.58
76.38%
4.40
21.10%
8.72
98.32%
0.62
92.87%
1.38
121.60%
0.62
55.10%
3.05
393.19%
1.53
49.97%
0.53
65.61%
working capital
22.69M
-
16.58M
26.91%
14.37M
13.34%
25.77M
79.35%
4.83M
81.24%
10.97M
126.99%
13.45M
22.51%
40.94M
204.48%
21.84M
46.66%
12.09M
44.63%

All numbers in USD (except ratios and percentages)